SEER seer.bio: Multiplikator Forward P/S

The forward P/S metric for Seer, Inc. (SEER) exhibits a trend where 6.40 determines the current status of the parameter. Growth is driven by pharmaceutical laboratories' demand for biomarker discovery and the implementation of eco-friendly cartridge recycling systems. Price stability is supported by the diversification of electronics suppliers, which protects the margins of precision protein analysis platform assembly and minimizes component shortage risks.

seer.bio - Rasio kapitalisasi marang dodolan sing dikarepake SEER (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan Seer Bio (SEER)

- rega saiki lan proyeksi nilai saham:

Rega saham Seer|SEER - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Seer Bio|SEER - Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham Seer|SEER - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku seer.bio|SEER - Gunggung Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

- rincian asil keuangan lan kelipatan valuasi:

SEER - Bathi resik taunan|Bathi mangsa ngarep Seer, Inc.|SEER - Pangali P/E|Pangali Forward P/E Seer Inc.|SEER - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Seer Bio|SEER - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Seer|SEER - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan seer.bio|SEER - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Seer, Inc.

- indikator volume dodolan lan pendapatan:

SEER - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Seer|SEER - Kapitalisasi marang volume dodolan|Rasio rega marang prakiraan pendapatan Seer Bio

Ringkesan analitik perusahaan:Seer (SEER)

This indicator assesses the current market value of Seer, Inc. (SEER) relative to its expected sales, neutralizing the time lag between stock quotes and financial reporting. By analyzing the forward P/S multiple, an investor determines the market's confidence in the expansion of the Proteograph platform within the B2B diagnostics segment, where inflated values may signal that the asset is overbought and indicate a reduced margin of safety amid rising interest rates.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|mesalabs.com - Rasio rega marang prakiraan pendapatan|QSI: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NNOX (Nano-X Imaging)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908 Devices Corporation (MASS)|Rasio rega marang prakiraan pendapatan CapsoVision, Inc.|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan RPID (Rapid Micro Biosystems)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)